Down syndrome screening in assisted conception twins: An iatrogenic medical challenge

Obstetrical and Gynecological Survey

Volumn 68, Issue 11, 2013, Pages 764-773

  Ben Ami, Ido ^a   Maymon, Ron ^a   Svirsky, Ran ^a   Cuckle, Howard ^b   Jauniaux, Eric ^c  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b Columbia University School of Medicine ^*  (United States)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL;

DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; EARLY DIAGNOSIS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; INFERTILITY THERAPY; MATERNAL SERUM; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL CARE; PRENATAL SCREENING; REVIEW; SECOND TRIMESTER PREGNANCY; SYSTEMATIC REVIEW; TWIN PREGNANCY;

DISEASES IN TWINS; DOWN SYNDROME; FEMALE; HUMANS; IATROGENIC DISEASE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTERS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; REPRODUCTIVE TECHNIQUES, ASSISTED; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84888258567     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0000000000000001     Document Type: Review

References (69)

1. ESHRE Campus Course Report. Prevention of twin pregnancies after IVF/ICSI by single embryo transfer. Hum Reprod.2001;16:790-800
2. Luke B, Brown MB, Grainger DA, et al. A Society for Assisted Reproductive Technology Writing Group. Practice patterns and outcomes with the use of single embryo transfer in United States. Fertil Steril. 2010;93:490-498
3. ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2005. Results generated from European Registers by ESHRE. Hum Reprod. 2009;24:1267-1287
4. ESHRE Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod. 2000;15:1856-1864
5. Maheshwari A, Griffiths S, Bhattacharya S. Global variations in the uptake of single embryo transfer. Hum Reprod Update. 2011;17:107-120
6. Botting BJ, Macdonald Davies J, Macfarlane AJ. Recent trends in the incidence of multiple birth and associated mortality. Arch Dis Child. 1987;62:941-950
7. Kidd SA, Lancaster PA, Anderson JC, et al. A cohort study of pregnancy outcome after amniocentesis in twin pregnancy. Paediatr Perinat Epidemiol. 1997;11:200-213
8. Yukobowich E, Anteby EY, Cohen SM, et al. Risk of fetal loss in twin pregnancies undergoing second trimester amniocentesis. Obstet Gynecol. 2001;98:231-234
9. Holmes A, Jauniaux E. Prospective study of parental choice for aneuploidy screening in assisted conception versus spontaneously conceived twins. Reprod Biomed Online. 2004;8: 243-245
10. Daskalakis G, Anastasakis E, Papantoniou N, et al. Second trimester amniocentesis in assisted conception versus spontaneously conceived twins. Fertil Steril. 2009;91:2572-2577
11. Geipel A, Berg C, Katalinic A, et al. Different preferences for prenatal diagnosis in pregnancies following assisted reproduction versus spontaneous conception. Reprod Biomed Online. 2004;8:119-124
12. Cahill AG, Macones GA, Stamilio DM, et al. Pregnancy loss rate after mid-Trimester amniocentesis in twin pregnancies. Am J Obstet Gynecol. 2009;200:257
13. Vink J, Fuchs K, D'Alton ME. Amniocentesis in twin pregnancies: A systematic review of the literature. Prenat Diagn. 2012;32: 409-416
14. Agarwal K, Alfirevic Z. Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnanciesVa systematic review. Ultrasound Obstet Gynecol. 2012;40: 128-134
15. Wimalasundera RC. Selective reduction and termination of multiple pregnancies. Semin Fetal Neonatal Med. 2010;15: 327-335
16. Brambati B, Tului L, Baldi M, et al. Genetic analysis prior to selective fetal reduction in multiple pregnancy: Technical aspects and clinical outcome. Hum Reprod. 1995;10: 818-825
17. Pergament E, Schulman JD, Copeland K, et al. The risk and efficacy of chorionic villus sampling in multiple gestations. Prenat Diagn. 1992;12:377-384
18. Cuckle H. Down's syndrome screening in twins. J Med Screen. 1998;5:3-4
19. Spencer K, Salonen R, Muller F. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG. Prenat Diagn. 1994;14:537-542
20. Wald N, Cuckle H, Wu TS, et al. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: Implications for screening for Down's syndrome. Br J Obstet Gynaecol. 1991;98:905-908
21. Wald NJ, Kennard A, Hackshaw A, et al. Antenatal screening for Down's syndrome. J Med Screen. 1997;4:181-246
22. Spencer K, Nicolaides KH. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: A review of three years experience. BJOG. 2003;110:276-280
23. Cuckle H, Benn P. Multi-marker maternal serum screening for chromosomal abnormalities. In: Milunsky A, Milunsky JM, eds. Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment. Baltimore, MD: Johns Hopkins University Press; 2010:771-818
24. Räty R, Virtanen A, Koskinen P, et al. Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies. Prenat Diagn. 2000;20:221-223
25. Maymon R, Neeman O, Shulman A, et al. Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: Another double trouble. Prenat Diagn. 2005;25: 746-750
26. Maymon R, Cuckle H, Herman A. Maternal serum inhibin levels in twin and singleton pregnancies conceived by assisted reproduction. Hum Reprod. 2006;21:1305-1308
27. Wenstrom KD, Syrop CH, Hammitt DG, et al. Increased risk of monochorionic twinning associated with assisted reproduction. Fertil Steril. 1993;60:510-514
28. Sepulveda W. Chorionicity determination in twin pregnancies: Double trouble. Ultrasound Obstet Gynecol. 1997;10: 79-81
29. Shetty A, Smith AP. The sonographic diagnosis of chorionicity. Prenat Diagn. 2005;25:735-739
30. Ministry of Health, Israel. Screening for Down's syndrome for high risk pregnant women. [in Hebrew]. Available at: Www.health.gov.il. Accessed July 29, 2013
31. Maymon R, Dreazen E, Rozinsky S, et al. Comparison of nuchal translucency measurement and second-Trimester triple serum screening in twin versus singleton pregnancies. Prenat Diagn. 1999;19:727-731
32. Maymon R, Jauniaux E. Down's syndrome screening in pregnancies after assisted reproductive techniques: An update. Reprod Biomed Online. 2002;4:285-293
33. Pandya PP, Snijders RJ, Johnson SP, et al. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol. 1995;102:957-962
34. Cuckle H, Maymon R. Down syndrome risk calculation for a twin fetus taking account of the nuchal translucency in the co-Twin. Prenat Diagn. 2010;30:827-833
35. Wald NJ, Rish S, Hackshaw AK. Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies. Prenat Diagn. 2003;23:588-592
36. Wøjdemann KR, Larsen SO, Shalmi AC, et al. Nuchal translucency measurements are highly correlated in both monoand dichorionic twin pairs. Prenat Diagn. 2006;26:218-220
37. Maymon R, Rosen H, Baruchin O, et al. Model predicted Down syndrome detection rates for nuchal translucency screening in twin pregnancies. Prenat Diagn. 2011;31:426-429
38. Orlandi F, Rossi C, Allegra A, et al. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn. 2002;22: 718-721
39. Maiz N, Staboulidou I, Leal AM, et al. Ductus venosus Doppler at 11 to 13 weeks of gestation in the prediction of outcome in twin pregnancies. Obstet Gynecol. 2009;113:860-865
40. Sepulveda W, Wong AE, Casasbuenas A. Nuchal translucency and nasal bone in first-Trimester ultrasound screening for aneuploidy in multiple pregnancies. Ultrasound Obstet Gynecol. 2009;33:152-156
41. Cleary-Goldman J, Rebarber A, Krantz D, et al. First-Trimester screening with nasal bone in twins. Am J Obstet Gynecol. 2008;199:283e1-283e3
42. Zoppi MA, Ibba RM, Axiana C, et al. Absence of fetal nasal bone and aneuploidies at first-Trimester nuchal translucency screening in unselected pregnancies. Prenat Diagn. 2003;23: 496-500
43. Linskens IH, Spreeuwenberg MD, Blankenstein MA, et al. Early first-Trimester free beta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins. Prenat Diagn. 2009; 29:74-78
44. Koster MP, Wortelboer EJ, Stoutenbeek P, et al. Distributions of current and new first-Trimester Down syndrome screening markers in twin pregnancies. Prenat Diagn. 2010;30:413-417
45. Madsen HN, Ball S, Wright D, et al. A reassessment of biochemical marker distributions in trisomy 21-Affected and unaffected twin pregnancies in the first trimester. Ultrasound Obstet Gynecol. 2011;37:38-47
46. Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester: Does chorionicity impact on maternal serum free beta-hCG or PAPP-A levels? Prenat Diagn. 2001;21:715-717
47. Goncé A, Borrell A, Fortuny A, et al. First-Trimester screening for trisomy 21 in twin pregnancy: Does the addition of biochemistry make an improvement? Prenat Diagn. 2005;25: 1156-1161
48. Spencer K, Kagan KO, Nicolaides KH. Screening for trisomy 21 in twin pregnancies in the first trimester: An update of the impact of chorionicity on maternal serum markers. Prenat Diagn. 2008;28:49-52
49. Prats P, Rodríguez I, Nicolau J, et al. Early first-Trimester freebeta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins. Prenat Diagn. 2012;32:64-69
50. Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn. 2000;20: 91-95
51. Jauniaux E, Elkazen N, Leroy F, et al. Clinical and morphologic aspects of the vanishing twin phenomenon. Obstet Gynecol. 1988;72:577-581
52. Landy HJ, Keith LG. The vanishing twin: A review. Hum Reprod Update. 1998;4:177-183
53. Dickey RP, Taylor SN, Lu PY, et al. Spontaneous reduction of multiple pregnancy: Incidence and effect on outcome. Am J Obstet Gynecol. 2002;186:77-83
54. Greenwold N, Jauniaux E. Collection of villous tissue under ultrasound guidance to improve the cytogenetic study of early pregnancy failure. Hum Reprod. 2002;17:452-456
55. Jauniaux E, Van Oppenraaij RH, Burton GJ. Obstetric outcome after early placental complications. Curr Opin Obstet Gynecol. 2010;22:452-457
56. Barton SE, Missmer SA, Hornstein MD. Twin pregnancies with a 'vanished' embryo: A higher risk multiple gestation group? Hum Reprod. 2011;26:2750-2753
57. Kelly MP, Molo MW, Maclin VM, et al. Human chorionic gonadotropin rise in normal and vanishing twin pregnancies. Fertil Steril. 1991;56:221-224
58. Gjerris AC, Loft A, Pinborg A, et al. The effect of a 'vanishing twin' on biochemical and ultrasound first trimester screening markers for Down's syndrome in pregnancies conceived by assisted reproductive technology. Hum Reprod. 2009;24: 55-62
59. Gjerris AC, Tabor A, Loft A, et al. First trimester prenatal screening among women pregnant after IVF/ICSI. Hum Reprod Update. 2012;18:350-359
60. Ben-Ami I, Edel Y, Barel O, et al. Do assisted conception twins have an increased risk for anencephaly? Hum Reprod. 2011; 26:3466-3471
61. Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment. Prenat Diagn. 2011; 31:3-6
62. Svirsky R, Meiri H, Herzog A, et al. First trimester maternal serum placental protein 13 levels in singleton vs. twin pregnancies with and without severe pre-eclampsia. J Perinat Med. 2013;16:1-6
63. Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn. 2011;31:66-74
64. Benn P, Cuckle H, Pergament E. Non-invasive prenatal diagnosis for aneuploidyVcurrent status and future prospects. Ultrasound Obstet Gynecol. 2013;42:15-33
65. Canick JA, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn. 2012; 32:730-734
66. Lau TK, Jiang F, Chan MK, et al. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies. J Matern Fetal Neonatal Med. 2013;26:434-437
67. Benn P, Cuckle H, Pergament E. Opinion: Non-invasive prenatal diagnosis for Down syndrome: The paradigm will shift, but slowly. Ultrasound Obstet Gynecol. 2012;39:127-130
68. Ben-Ami I, Maymon R. Prenatal diagnosis after assisted reproductive technology. In: Jauniaux ERM, Rizk BRMB, eds. Pregnancy After Assisted Reproductive Technology. Cambridge University Press Cambridge, UK; 2012;149-167
69. Hui PW, Tang MH,Ng EH, et al.Nuchal translucency in dichorionic twins conceived after assisted reproduction. Prenat Diagn. 2006;26:510-13